Preparation method and application of decellularized extracellular matrix tissue paper

Patent metadata

Field	Value
Publication number	US-12257364-B2
Application number	US-202318122009-A
Country	US
Kind code	B2
Filing date	Mar 15, 2023
Priority date	May 31, 2022
Publication date	Mar 25, 2025
Grant date	Mar 25, 2025

Abstract

The present disclosure discloses a preparation method and application of decellularized extracellular matrix tissue paper, and belongs to the technical field of regenerative medicine. The preparation method includes the following steps: (1) preparing decellularized extracellular matrix materials; (2) preparing tissue paper: homogenizing and stirring the prepared decellularized extracellular matrix materials, then, placing the obtained homogenates on a flat-bottom filter screen to filter out water, standing and air-drying the filtered homogenates, and freeze-drying the homogenates to obtain the tissue paper; (3) cross-linking the tissue paper: cross-linking the tissue paper in a cross-linking solution; and (4) freeze-drying or stacking and compacting the cross-linked tissue paper. According to the present disclosure, the decellularized extracellular matrix tissue paper with tissue specificity is prepared by a traditional paper-making technology combined with a freeze-drying technology.

First claim

What is claimed is:

1. A preparation method of decellularized extracellular matrix tissue paper, comprising the following steps:
(1) preparing decellularized extracellular matrix materials, comprising:
washing a tissue with water and then slicing the tissue;
disinfecting the washed sliced tissue with a peroxyacetic acid;
washing the disinfected tissue by adding sterilized water or normal saline; and
further washing the disinfected tissue with a buffer containing DNase and RNase so as to remove DNA and RNA;

(2) preparing tissue paper, comprising:
homogenizing and stirring the decellularized extracellular matrix materials from step (1) for a time ranging from 1 minute to 60 minutes to obtain a homogenate;
placing the obtained homogenate on a flat-bottom filter screen to filter out water from the obtained homogenate to obtain filtered homogenate, wherein the water passes through the flat-bottom filter screen, and air-drying the filtered homogenate on the flat-bottom filter screen to obtain air-dried homogenate, wherein placing the obtained homogenate on the flat-bottom filter screen and air-drying the filtered homogenate is performed in a range of from 1 hour to 120 hours; and
freeze-drying the air-dried homogenate at a temperature ranging from −196° C. to −20° C. for 4 hours to 48 hours, to obtain the tissue paper

(3) cross-linking the tissue paper, comprising:
cross-linking the tissue paper obtained in step (2) in a cross-linking solution, wherein the cross-linking solution in step (3) is an ethanol solution containing a cross-linking agent, the cross-linking agent comprising one or more of 1-ethyl-(3-dimethylaminopropyl) carbonyldiimine, N-hydroxysuccinimide, glutaraldehyde, formaldehyde, and genipin, and wherein the cross-linking is conducted at a temperature of 4° C. to 27° C. for 4 hours to 12 hours; and

(4) freeze-drying the cross-linked tissue paper, comprising:
freeze-drying the cross-linked tissue paper obtained in step (3), to obtain the decellularized extracellular matrix tissue paper, wherein the freeze-drying temperature in step (4) ranges from −196° C. to −20° C. for 12 hours to 72 hours.

2. The preparation method according to claim 1 , wherein the tissue comprises tissue or from a human body or an animal.

3. The preparation method according to claim 2 , wherein the tissue comprises cerebrum, heart, liver, spleen, lungs, kidneys, muscles, skin, fat, meninges, diaphragm, amnion, pericardium, heart valves, small intestine submucosa, blood vessels, tendons, ligaments, cartilage, esophagus, trachea, stomach, nerves, bladder, cornea and/or placenta.

4. The decellularized extracellular matrix tissue paper prepared by the preparation method according to claim 1 .

5. The decellularized extracellular matrix tissue paper prepared by the preparation method according to claim 2 .

6. The decellularized extracellular matrix tissue paper prepared by the preparation method according to claim 3 .

7. A preparation method of decellularized extracellular matrix porcine heart tissue paper, comprising the following steps:
(1) preparing decellularized extracellular matrix materials, comprising:
washing a porcine heart tissue with water, and then slicing the tissue to a thickness of 1 mm, and placing the sliced tissue into a glass bottle;
disinfecting and sterilizing the washed sliced tissue with a 0.1% peroxyacetic acid;
washing the disinfected and sterilized tissue by adding sterilized water and shaking on a shaker until a solution containing the disinfected and sterilized tissue becomes clear;
further washing the disinfected and sterilized tissue with a 1% sodium dodecyl sulfate (SDS) solution while shaking on a shaker for 72 hours, and changing the SDS solution once every three hours, until the tissue becomes white;
washing the white tissue by adding sterilized water to remove residual SDS;
adding a Tris-HCL buffer with DNase and RNase to the washed tissue to form a mixture, and then shaking the mixture on a shaker at 37° C. and 100 rpm for 24 hours to remove DNA and RNA from the tissue; and
washing the mixture with sterilized water to obtain porcine heart extracellular matrix material;

(2) preparing tissue paper, comprising:
placing 10 grams of the porcine heart extracellular matrix material from step (1) in 100 mL of distilled water to form a mixture;
homogenizing the mixture for 10 minutes to obtain a homogenate;
placing the homogenate on a flat-bottom filter screen having a diameter of 8 cm to filter out water from the obtained homogenate to obtain filtered homogenate, and air-drying the filtered homogenate on the flat-bottom filter screen at room temperature to obtain air-dried homogenate, wherein the filtering and air-drying are performed for a total of 48 hours;
freezing the filtered and air-dried homogenate at −80° C. for 4 hours to produce a frozen homogenate; and
transferring the frozen homogenate to a freeze-dryer for freeze-drying to obtain porcine heart tissue paper;

(3) cross-linking the porcine heart tissue paper, comprising:
preparing 100 mL of 80% ethanol solution and adding1-ethyl-(3-dimethylaminopropyl) carbonyldiimine (EDC) and N-hydroxysuccinimide (NHS) at a mass ratio of 4:1 to the ethanol solution to prepare a cross-linking solution with a concentration of 0.3%;
immersing the porcine heart tissue paper into the cross-linking solution at 4° C. for 10 hours to obtain cross-linked porcine heart tissue paper; and
removing the cross-linked porcine heart tissue paper from the cross-linking solution, and soaking and washing the removed cross-linked porcine heart tissue paper with sterilized water several times to remove residual cross-linking agents; and

(4) freeze-drying the cross-linked porcine heart tissue paper, comprising:
freeze-drying the cross-linked porcine heart tissue paper obtained in step (3) by freezing at −20° C. for 12 hours, and then freeze-drying in a freeze dryer for 48 hours, to obtain the decellularized extracellular matrix porcine heart tissue paper.

Assignees

• Univ Nankai

Inventors

• Zhu Meifeng
• Li Wen
• Kong Deling
• Zhang Zhen

Classifications

• A61L2430/40

  Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking · CPC title

• A61L27/3633 Primary

  Extracellular matrix [ECM] · CPC title

• A61L27/3604

  characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel · CPC title

• A61L27/3691

  characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation · CPC title

• A61L2300/412

  Tissue-regenerating or healing or proliferative agents · CPC title